The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Correlations of molecular alterations in clinical stage III cutaneous melanoma with clinical-pathological features and patients outcome.
Piotr Rutkowski
Consultant or Advisory Role - Bristol-Myers Squibb; MSD; Novartis
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Pfizer; Roche
Monika Jurkowska
No relevant relationships to disclose
Aleksandra Gos
No relevant relationships to disclose
Andrzej Tysarowski
No relevant relationships to disclose
Wanda Michej
No relevant relationships to disclose
Tomasz Switaj
No relevant relationships to disclose
Wirginiusz Dziewirski
No relevant relationships to disclose
Marcin Zdzienicki
No relevant relationships to disclose
Slawomir Falkowski
No relevant relationships to disclose
Wlodzimierz Tadeusz Olszewski
No relevant relationships to disclose
Janusz A Siedlecki
No relevant relationships to disclose